Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: the EUROMACS registry.

European heart journal·2026
Same author

Peak Oxygen Uptake for Risk Stratification in Fully Magnetically Levitated Left Ventricular Assist Device Recipients.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Generation of a STRAIGHT-IN Dual AAVS1 hiPSC line with orthogonal landing pads for versatile DNA payload integration.

Stem cell research·2026
Same author

Cardiomyopathy phenotypes caused by a heterozygous MYBPC3 mutation revealed in different hiPSC cardiac models.

Experimental cell research·2026
Same author

Reply to 'Beyond socioeconomic status: structural determinants and strategic approaches to regional variation in left ventricular assist device utilization'.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

In vitro modeling of renal injury-induced cardiac effects using human iPSC-derived organoids.

Cell communication and signaling : CCS·2026

関連する実験動画

Updated: May 5, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

9.9K

幹細胞ベースの治療法と心臓からの教訓

Robert Passier1, Linda W van Laake, Christine L Mummery

  • 1Hubrecht Institute, Developmental Biology and Stem Cell Research, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.

Nature
|May 16, 2008
PubMed
まとめ

人間の胚性幹細胞は,治療的な可能性を秘めているが,倫理的な懸念も提起している. 大人の幹細胞は心臓の修復に希望を示していますが,心筋細胞の再生は依然として課題です.

科学分野:

  • 再生医学は,再生医療である.
  • 心臓病学 心臓病学
  • 幹細胞生物学 幹細胞生物学

背景:

  • 人間の胚性幹細胞 (hESCs) は多能性を持ち,任意の細胞型に差異化することを可能にし,倫理的な議論にもかかわらず治療研究を推進しています.
  • 成人幹細胞は,再生療法におけるhESCの代替品として調査されており,心臓の応用において顕著な進展が見られます.
  • 心筋細胞 (心筋細胞) は,成人では再生能力が限られており,怪我後の自然修復を妨げています.

研究 の 目的:

  • 心臓の修復のための幹細胞の治療の可能性を評価する.
  • 血管新生を促進したり,定住幹細胞を活性化したりするなどの代替戦略と比較して,心筋細胞置換の有効性を比較する.
  • 心臓病のための幹細胞移植に関する最近の臨床前および臨床的発見をレビューする.

主な方法:

  • 心臓再生のための幹細胞療法に関する科学文献のレビュー.
  • 動物モデルでの心筋細胞移植を含む臨床前研究の分析.
  • 心臓病に対する成人の幹細胞を用いた臨床試験の初期段階の検討.

主要な成果:

  • 動物での臨床前研究では,心筋細胞移植の有望な結果が得られたが,その結果は変化している.
  • 大人の幹細胞を心臓の修復のために利用した初期臨床試験は,さまざまな結果を示しています.

さらに関連する動画

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.3K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

7.4K

関連する実験動画

Last Updated: May 5, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

9.9K
Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

6.3K
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

7.4K
  • 心臓修復の最適な戦略―直接心筋細胞置換または代替方法―については,さらなる調査が必要である.

    • 結論:

    • 幹細胞ベースの治療法は心臓病の治療に潜在力を秘めているが,依然として大きな課題が残っている.
    • 心臓再生のための最も効果的な幹細胞源と治療アプローチを明確にするために,さらなる研究が必要です.
    • 成人性心筋細胞の限られた再生能力に対処することは,心臓修復戦略を前進させるために不可欠です.